NMPA's new BCI classification rules set device risk classes, a first regulatory gate for foreign investors in China neurotech.
European marketing authorization follows U.S. FDA clearance of eyonis LCS, Median's AI-based Software as a Medical Device designed to aid in the detection and diagnosis of lung cancer in screening ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...
Medical innovation often looks impressive from the outside. A new diagnostic tool reaches hospitals. A wearable device helps patients track their health at home. A surgical system becomes more precise ...
While design is crucial to make prosthetics or robot pants people actually want to wear, lessons from loyalty programs could ...
Butterfly Network, Inc. (“Butterfly”) (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the commercial availability of ...
The US Food and Drug Administration (FDA) recently warned a distributor and medical device maker for marketing continuous positive airway pressure (CPAP) machines and related software for treating ...
It is barely the second quarter of the year, yet the Kenyan healthcare regulatory landscape is being redrawn. Two documents released in 2026 will be major determinants of how pharmacies, clinics, ...
Brian Miller shares how he built his career, what it was like at Intuitive as the device developer grew, and advice for ...
IITs are revolutionizing engineering education with interdisciplinary M.Tech programs, fostering collaboration across diverse ...
Discover how automation, AI, and organoid technologies are improving drug discovery through scalable workflows.
In this interview, AZoLife Sciences speaks with Boyd Butler, a microscopy and high-content screening expert at Molecular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results